Notice: This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends UPTD vs. BCDA, KLTO, ONVO, PALI, CELZ, ALBT, FRTX, CERO, TTNP, and GENEShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include BioCardia (BCDA), Klotho Neurosciences (KLTO), Organovo (ONVO), Palisade Bio (PALI), Creative Medical Technology (CELZ), Avalon GloboCare (ALBT), Fresh Tracks Therapeutics (FRTX), CERo Therapeutics (CERO), Titan Pharmaceuticals (TTNP), and Genetic Technologies (GENE). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. BioCardia Klotho Neurosciences Organovo Palisade Bio Creative Medical Technology Avalon GloboCare Fresh Tracks Therapeutics CERo Therapeutics Titan Pharmaceuticals Genetic Technologies TradeUP Acquisition (NASDAQ:UPTD) and BioCardia (NASDAQ:BCDA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Do institutionals and insiders believe in UPTD or BCDA? 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 20.6% of BioCardia shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by company insiders. Comparatively, 20.0% of BioCardia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to UPTD or BCDA? In the previous week, BioCardia had 6 more articles in the media than TradeUP Acquisition. MarketBeat recorded 6 mentions for BioCardia and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat BioCardia's score of 0.64 indicating that TradeUP Acquisition is being referred to more favorably in the media. Company Overall Sentiment TradeUP Acquisition Positive BioCardia Positive Which has higher valuation and earnings, UPTD or BCDA? TradeUP Acquisition has higher earnings, but lower revenue than BioCardia. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTradeUP AcquisitionN/AN/A-$1MN/AN/ABioCardia$71K149.79-$11.57M-$4.19-0.55 Do analysts prefer UPTD or BCDA? BioCardia has a consensus price target of $25.00, suggesting a potential upside of 977.59%. Given BioCardia's stronger consensus rating and higher probable upside, analysts plainly believe BioCardia is more favorable than TradeUP Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TradeUP Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioCardia 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, UPTD or BCDA? TradeUP Acquisition has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, BioCardia has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Is UPTD or BCDA more profitable? TradeUP Acquisition has a net margin of 0.00% compared to BioCardia's net margin of -1,999.77%. Company Net Margins Return on Equity Return on Assets TradeUP AcquisitionN/A N/A -3.38% BioCardia -1,999.77%N/A -208.38% Does the MarketBeat Community favor UPTD or BCDA? BioCardia received 16 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTradeUP AcquisitionN/AN/ABioCardiaOutperform Votes1659.26% Underperform Votes1140.74% SummaryBioCardia beats TradeUP Acquisition on 7 of the 13 factors compared between the two stocks. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.54M$3.09B$5.62B$9.14BDividend YieldN/A1.87%5.36%3.98%P/E RatioN/A46.7489.6917.66Price / SalesN/A297.571,220.3881.09Price / CashN/A188.8944.3437.71Price / Book-0.744.145.134.73Net Income-$1M-$40.99M$118.85M$225.42M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$1.17+5.6%N/A-9.0%$2.54MN/A0.002,021Gap DownBCDABioCardia3.6428 of 5 stars$2.18flat$25.00+1,046.8%-68.4%$9.99M$480,000.000.0040Short Interest ↓News CoverageKLTOKlotho NeurosciencesN/A$0.45+9.8%N/AN/A$8.68MN/A0.00N/ANews CoverageGap UpONVOOrganovo0.6879 of 5 stars$0.38-0.8%N/A-66.9%$5.95M$110,000.000.0020Analyst ForecastShort Interest ↓PALIPalisade Bio3.1544 of 5 stars$1.51+2.0%$23.00+1,423.2%-90.1%$4.09M$250,000.000.0010Short Interest ↓News CoverageGap UpCELZCreative Medical Technology1.5819 of 5 stars$2.33+2.6%N/A-24.8%$4.08M$10,000.00-0.615Short Interest ↓News CoverageGap DownALBTAvalon GloboCare1.7863 of 5 stars$3.73+1.9%N/A-43.7%$4.07M$1.26M-0.195Short Interest ↓Gap DownFRTXFresh Tracks TherapeuticsN/A$0.66flatN/A-5.1%$3.94M$8.01M0.0020News CoverageCEROCERo TherapeuticsN/A$2.31-1.3%N/AN/A$3.52MN/A0.008Short Interest ↓Gap UpTTNPTitan Pharmaceuticals1.2222 of 5 stars$3.46-9.9%N/A-43.0%$3.51M$180,000.000.0010Analyst ForecastGap UpHigh Trading VolumeGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050News CoverageHigh Trading Volume Related Companies and Tools Related Companies BioCardia Alternatives Klotho Neurosciences Alternatives Organovo Alternatives Palisade Bio Alternatives Creative Medical Technology Alternatives Avalon GloboCare Alternatives Fresh Tracks Therapeutics Alternatives CERo Therapeutics Alternatives Titan Pharmaceuticals Alternatives Genetic Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UPTD) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
